This inventor holds 2 USPTO granted patents. Top assignee: Richardson-Merrell Inc.. Active years: 1976-1980.
Company Filing History:
Years Active: 1976-1980
Title: David Lawrence Wenstrup: Innovator in Pharmaceutical Chemistry
Introduction
David Lawrence Wenstrup is a notable inventor based in Edgewood, KY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that have therapeutic applications.
Latest Patents
Wenstrup holds 2 patents that showcase his innovative work. His latest patents include a process for preparing 2-(2,2-dicyclohexylethyl)piperidine, which is achieved through the catalytic hydrogenation of 2-(2,2-diphenylethenyl)pyridine in a single step. This method yields high results using a rhodium-supported catalyst. Another significant patent involves dioxocin carboxamide derivatives, which are designed to reduce blood lipids in warm-blooded animals and are useful in treating hyperlipidemic states.
Career Highlights
Wenstrup is associated with Richardson-Merrell Inc., where he has been able to apply his expertise in pharmaceutical development. His work has contributed to advancements in the treatment of various medical conditions, particularly those related to lipid metabolism.
Collaborations
Throughout his career, Wenstrup has collaborated with esteemed colleagues such as Stephen W. Horgan and Frank P. Palopoli. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
David Lawrence Wenstrup is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving health outcomes through scientific research.